Overtreatment in epilepsy: adverse consequences and mechanisms

Area of Science:

• Pharmacology
• Neurology
• Clinical Pharmacy

Background:

• Complete seizure control is paramount for epilepsy patients' quality of life.
• Antiepileptic drug (AED) therapy aims for seizure freedom but must balance efficacy with side effects.
• Overtreatment with AEDs is a significant clinical issue, potentially causing more harm than the underlying condition.

Purpose of the Study:

• To review the various forms and mechanisms of antiepileptic drug overtreatment.
• To highlight the risks associated with inappropriate AED use, including unnecessary polypharmacy.
• To emphasize the importance of individualized treatment strategies in epilepsy management.

Main Methods:

• Review of literature on antiepileptic drug therapy and overtreatment.
• Analysis of different types of overtreatment, such as inappropriate duration, dose escalation, and polypharmacy.
• Discussion of pharmacokinetic and pharmacodynamic drug interactions in combination therapy.

Main Results:

• Overtreatment manifests as prolonged use of indicated therapy, rapid dose escalation, high maintenance doses, and unnecessary polypharmacy.
• Polypharmacy, especially with drug combinations, can lead to adverse drug-drug interactions (pharmacokinetic and pharmacodynamic).
• Some AED combinations may offer an improved therapeutic index, but careful clinical observation is essential to identify toxicity.

Conclusions:

• Optimizing epilepsy treatment requires avoiding overtreatment and focusing on individualized patient needs.
• Careful consideration of dose-response relationships, serum drug concentrations, and potential drug interactions is vital.
• Clinical vigilance is necessary to manage AEDs effectively and prevent treatment-related morbidity.